论文部分内容阅读
目的通过临床病例分析了解内科综合治疗对肝性脊髓病(HM)的疗效。方法回顾性分析了1990年5月至2010年5月我院收治的29例HM患者的临床表现及内科治疗效果。结果全组共缓解18例,无效11例,缓解率62.06%。A组(肌力≤2级)13例,缓解3例(缓解率23.1%);B组(肌力≥3级)16例,缓解15例(缓解率93.7%)。B组的缓解率明显高于A组(P<0.05)。结论 HM早期进行内科治疗,效果较佳。
Objective To understand the clinical effect of comprehensive medical treatment on hepatic myelopathy (HM). Methods Retrospective analysis of clinical manifestations and medical treatment of 29 patients with HM treated in our hospital from May 1990 to May 2010. Results The whole group of 18 cases were relieved, 11 cases were ineffective, the remission rate was 62.06%. Thirteen patients in group A (mitral strength ≤2) were treated with thrombolytic therapy, of which 13 were relieved (response rate was 23.1%); 16 were treated in group B (≥3 muscle strength), 15 were relieved (remission rate was 93.7%). The remission rate in group B was significantly higher than that in group A (P <0.05). Conclusion HM early medical treatment, the effect is better.